Page 265 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat
P. 265

Pathology  ` PATHOLOGY—neOPLASIA                            Pathology  ` PATHOLOGY—neOPLASIA          SECtIoN II       221




                  Hallmarks of cancer    Cancer is caused by (mostly acquired) DNA mutations that affect fundamental cellular processes
                                          (eg, growth, DNA repair, survival).
                   HALLMArK              MeCHAnISM
                   Growth signal         Mutations in genes encoding:
                    self-sufficiency         ƒ Proto-oncogenes Ž  growth factors Ž autocrine loop (eg,  PDGF in brain tumors)
                                             ƒ Growth factor receptors Ž constitutive signalling (eg, HER2/neu in breast cancer)
                                             ƒ Signaling molecules (eg, RAS)
                                             ƒ Transcription factors (eg, MYC)
                                             ƒ Cell cycle regulators (eg, cyclins, CDKs)
                   Anti-growth signal        ƒ Mutations in tumor suppressor genes (eg, Rb)
                    insensitivity            ƒ Loss of E-cadherin function Ž loss of contact inhibition (eg, NF2 mutations)
                   Evasion of apoptosis  Mutations in genes that regulate apoptosis (eg, TP53, BCL2 Ž follicular B cell lymphoma).
                   Limitless replicative   Reactivation of telomerase Ž maintenance and lengthening of telomeres Ž prevention of
                    potential             chromosome shortening and cell aging.
                   Sustained              pro-angiogenic factors (eg, VEGF) or  inhibitory factors. Factors may be produced by tumor or
                    angiogenesis          stromal cells. Vessels can sprout from existing capillaries (neoangiogenesis) or endothelial cells are
                                          recruited from bone marrow (vasculogenesis). Vessels may be leaky and/or dilated.
                   Tissue invasion       Loss of E-cadherin function Ž loosening of intercellular junctions Ž metalloproteinases degrade
                                          basement membrane and ECM Ž cells attach to ECM proteins (eg, laminin, fibronectin) Ž cells
                                          migrate through degraded ECM (“locomotion”) Ž vascular dissemination.
                   Metastasis            Tumor cells or emboli spread via lymphatics or blood Ž adhesion to endothelium Ž extravasation
                                          and homing. Site of metastasis can be predicted by site of 1° tumor, as the target organ is often the
                                          first-encountered capillary bed. Some cancers show organ tropism (eg, lung cancers commonly
                                          metastasize to adrenals).
                   Warburg effect        Shift of glucose metabolism away from mitochondrial oxidative phosphorylation toward glycolysis.
                   Immune evasion in     Normally, immune cells can recognize and attack tumor cells. For successful tumorigenesis, tumor
                    cancer                cells must evade the immune system. Multiple escape mechanisms exist:
                                             ƒ  MHC class I expression by tumor cells Ž cytotoxic T cells are unable to recognize tumor
                                            cells.
                                             ƒ Tumor cells secrete immunosuppressive factors (eg, TGF-β) and recruit regulatory T cells to
                                            down regulate immune response.
                                             ƒ Tumor cells up regulate immune checkpoint molecules, which inhibit immune response.




































          FAS1_2019_04-Pathol.indd   221                                                                                11/7/19   4:02 PM
   260   261   262   263   264   265   266   267   268   269   270